Birzeit Pharmaceutical Co (XPAE:BPC) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAE:BPC Birzeit Pharmaceutical Co XPAE:BPC
86 GF Score
Price $3.97
GF Value $4.34
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Birzeit Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Birzeit Pharmaceutical Co  (XPAE:BPC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Birzeit Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Birzeit Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Birzeit Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Birzeit Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Birzeit Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 1.80 1.72 1.65 1.64

Birzeit Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.48 1.34 1.64 1.44 1.33

XPAE:BPC vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Birzeit Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Birzeit Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Birzeit Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Birzeit Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


XPAE:BPC
86GF Score
Birzeit Pharmaceutical Co XPAE:BPC
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Birzeit Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Birzeit Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Birzeit Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.036/333.9520*333.9520
=3.036

Current CPI (Jun. 2026) = 333.9520.

Birzeit Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.203 241.428 3.047
201612 2.246 241.432 3.107
201703 2.356 243.801 3.227
201706 2.319 244.955 3.162
201709 2.408 246.819 3.258
201712 1.767 246.524 2.394
201803 1.834 249.554 2.454
201806 1.802 251.989 2.388
201809 1.862 252.439 2.463
201812 1.869 251.233 2.484
201903 1.936 254.202 2.543
201906 1.915 256.143 2.497
201909 1.980 256.759 2.575
201912 2.030 256.974 2.638
202003 2.039 258.115 2.638
202006 1.973 257.797 2.556
202009 2.014 260.280 2.584
202012 2.057 260.474 2.637
202103 2.080 264.877 2.622
202106 2.208 271.696 2.714
202109 2.307 274.310 2.809
202112 2.394 278.802 2.868
202203 2.479 287.504 2.879
202206 2.507 296.311 2.825
202209 2.552 296.808 2.871
202212 2.670 296.797 3.004
202303 2.751 301.836 3.044
202306 2.693 305.109 2.948
202309 2.771 307.789 3.007
202312 2.709 306.746 2.949
202403 2.605 312.332 2.785
202406 2.553 314.175 2.714
202409 2.572 315.301 2.724
202412 2.706 315.605 2.863
202503 2.639 319.799 2.756
202506 2.808 322.561 2.907
202509 2.836 324.800 2.916
202512 2.976 324.054 3.067
202603 2.968 330.213 3.002
202606 3.036 333.952 3.036

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Birzeit Pharmaceutical Co (XPAE:BPC) Overvalued in 2026?

Based on GuruFocus' analysis, Birzeit Pharmaceutical Co stock appears to be undervalued. The current stock price of $3.97 is trading 8.5% below its estimated GF Value™ of $4.34. GuruFocus considers Birzeit Pharmaceutical Co to be Fairly Valued.

Key valuation signals for XPAE:BPC:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $4.34 vs. price of $3.97 (8.5% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the XPAE:BPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Birzeit Pharmaceutical Co Business Description

Address 20 Shatella Street, Betunia Industrial Area, Ramallah, PSE
Birzeit Pharmaceutical Co operates as a pharmaceutical manufacturer in Palestine, producing a range of approximately 270 products across various production lines at four locations. Its portfolio comprises brands spanning multiple therapeutic areas. In addition to manufacturing, the company supplies its products to the local market through pharmacies and medical professionals.
86GF Score

Get the complete analysis for XPAE:BPC

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.97
Price
$4.34
GF Value